Literature DB >> 17890453

Lack of iNKT cells in patients with combined immune deficiency due to hypomorphic RAG mutations.

Ponpan Matangkasombut1, Muriel Pichavant, Doris E Saez, Silvia Giliani, Evelina Mazzolari, Andrea Finocchi, Anna Villa, Cristina Sobacchi, Patricia Cortes, Dale T Umetsu, Luigi D Notarangelo.   

Abstract

Hypomorphic mutations of the RAG genes in humans are associated with a spectrum of clinical and immunologic presentations that range from T(-) B(-) severe combined immune deficiency (SCID) to Omenn syndrome. In most cases, residual V(D)J recombination activity allows for development of few T-cell clones, which expand in the periphery and infiltrate target organs, resulting in tissue damage. Invariant natural killer T (iNKT) cells play an important immunoregulatory role and have been associated with protection against autoimmunity. We now report on 5 unrelated cases of combined immune deficiency due to hypomorphic RAG mutations, and demonstrate the absence of iNKT cells in all 5 patients. These findings suggest that lack of this important immunoregulatory cell population may contribute to the pathophysiology of Omenn syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17890453      PMCID: PMC2200812          DOI: 10.1182/blood-2007-06-096487

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

Review 1.  The regulatory role of Valpha14 NKT cells in innate and acquired immune response.

Authors:  Masaru Taniguchi; Michishige Harada; Satoshi Kojo; Toshinori Nakayama; Hiroshi Wakao
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

2.  Three-dimensional clustering of human RAG2 gene mutations in severe combined immune deficiency.

Authors:  B Corneo; D Moshous; I Callebaut; R de Chasseval; A Fischer; J P de Villartay
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

3.  Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome.

Authors:  B Corneo; D Moshous; T Güngör; N Wulffraat; P Philippet; F L Le Deist; A Fischer; J P de Villartay
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

4.  Unequal signal and coding joint formation in human V(D)J recombination.

Authors:  G H Gauss; M R Lieber
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

5.  CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition.

Authors:  M Chilosi; F Facchetti; L D Notarangelo; S Romagnani; G Del Prete; F Almerigogna; M De Carli; G Pizzolo
Journal:  Eur J Immunol       Date:  1996-02       Impact factor: 5.532

6.  V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations.

Authors:  A Villa; C Sobacchi; L D Notarangelo; F Bozzi; M Abinun; T G Abrahamsen; P D Arkwright; M Baniyash; E G Brooks; M E Conley; P Cortes; M Duse; A Fasth; A M Filipovich; A J Infante; A Jones; E Mazzolari; S M Muller; S Pasic; G Rechavi; M G Sacco; S Santagata; M L Schroeder; R Seger; D Strina; A Ugazio; J Väliaho; M Vihinen; L B Vogler; H Ochs; P Vezzoni; W Friedrich; K Schwarz
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

7.  Mutations in conserved regions of the predicted RAG2 kelch repeats block initiation of V(D)J recombination and result in primary immunodeficiencies.

Authors:  C A Gomez; L M Ptaszek; A Villa; F Bozzi; C Sobacchi; E G Brooks; L D Notarangelo; E Spanopoulou; Z Q Pan; P Vezzoni; P Cortes; S Santagata
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

8.  Intrathymic restriction and peripheral expansion of the T-cell repertoire in Omenn syndrome.

Authors:  S Signorini; L Imberti; S Pirovano; A Villa; F Facchetti; M Ungari; F Bozzi; A Albertini; A G Ugazio; P Vezzoni; L D Notarangelo
Journal:  Blood       Date:  1999-11-15       Impact factor: 22.113

9.  Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation.

Authors:  Asha B Pillai; Tracy I George; Suparna Dutt; Pearline Teo; Samuel Strober
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

10.  Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function.

Authors:  Daniel B Stetson; Markus Mohrs; R Lee Reinhardt; Jody L Baron; Zhi-En Wang; Laurent Gapin; Mitchell Kronenberg; Richard M Locksley
Journal:  J Exp Med       Date:  2003-10-06       Impact factor: 14.307

View more
  13 in total

1.  Acquired Omenn-like syndrome, a novel posttransplant autoaggression syndrome reversed by rapamycin.

Authors:  Donald C Vinh; Khalid Bin Dhuban; Helen Mason; Duncan Lejtenyi; Sungmi Jung; Donald C Sheppard; Damien Faury; Nada Jabado; Ciriaco A Piccirillo
Journal:  Clin Vaccine Immunol       Date:  2011-11-16

Review 2.  RAG gene defects at the verge of immunodeficiency and immune dysregulation.

Authors:  Anna Villa; Luigi D Notarangelo
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

3.  Invariant natural killer (iNK) T cell deficiency in patients with common variable immunodeficiency.

Authors:  D A Fulcher; D T Avery; N L Fewings; L J Berglund; S Wong; D S Riminton; S Adelstein; S G Tangye
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

4.  Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID.

Authors:  Neslihan Edeer Karaca; Guzide Aksu; Ferah Genel; Nesrin Gulez; Sema Can; Yesim Aydinok; Serap Aksoylar; Emin Karaca; Imren Altuglu; Necil Kutukculer
Journal:  Clin Exp Med       Date:  2009-05-21       Impact factor: 3.984

Review 5.  Human RAG mutations: biochemistry and clinical implications.

Authors:  Luigi D Notarangelo; Min-Sung Kim; Jolan E Walter; Yu Nee Lee
Journal:  Nat Rev Immunol       Date:  2016-03-21       Impact factor: 53.106

6.  Lack of nonfunctional B-cell receptor rearrangements in a patient with normal B cell numbers despite partial RAG1 deficiency and atypical SCID/Omenn syndrome.

Authors:  Line Ohm-Laursen; Christian Nielsen; Niels Fisker; Søren Thue Lillevang; Torben Barington
Journal:  J Clin Immunol       Date:  2008-07-01       Impact factor: 8.317

7.  DOCK8 is critical for the survival and function of NKT cells.

Authors:  Greg Crawford; Anselm Enders; Uzi Gileadi; Sanda Stankovic; Qian Zhang; Teresa Lambe; Tanya L Crockford; Helen E Lockstone; Alexandra Freeman; Peter D Arkwright; Joanne M Smart; Cindy S Ma; Stuart G Tangye; Christopher C Goodnow; Vincenzo Cerundolo; Dale I Godfrey; Helen C Su; Katrina L Randall; Richard J Cornall
Journal:  Blood       Date:  2013-08-08       Impact factor: 22.113

Review 8.  Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency.

Authors:  Ottavia M Delmonte; Anna Villa; Luigi D Notarangelo
Journal:  Blood       Date:  2020-02-27       Impact factor: 22.113

9.  Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses.

Authors:  Silke Paust; Harvinder S Gill; Bao-Zhong Wang; Michael P Flynn; E Ashley Moseman; Balimkiz Senman; Marian Szczepanik; Amalio Telenti; Philip W Askenase; Richard W Compans; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2010-10-24       Impact factor: 25.606

10.  The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function.

Authors:  Michela Locci; Elena Draghici; Francesco Marangoni; Marita Bosticardo; Marco Catucci; Alessandro Aiuti; Caterina Cancrini; Laszlo Marodi; Teresa Espanol; Robbert G M Bredius; Adrian J Thrasher; Ansgar Schulz; Jiri Litzman; Maria Grazia Roncarolo; Giulia Casorati; Paolo Dellabona; Anna Villa
Journal:  J Exp Med       Date:  2009-03-23       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.